StonvexLoading…
StonvexStonvexStonvexCore line items from ABLV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $105.20M | $126.76M | $129.28M | $145.26M |
Operating Income | $-486.61K | $-206.04K | $11.33M | $10.14M |
Net Income | $820.02K | $-7.42M | $9.75M | $7.90M |
EPS (Diluted) | $0.02 | $-0.17 | $0.24 | $0.20 |
Total Assets | $34.55M | $47.63M | $54.91M | $54.62M |
Total Liabilities | $26.78M | $40.54M | $43.49M | $49.09M |
Cash & Equivalents | $9.01M | $15.19M | $13.33M | $5.77M |
Free Cash Flow OCF − CapEx | $1.17M | $-2.31M | $23.51M | $-13.05M |
Shares Outstanding | 49.39M | 42.56M | 39.45M | 37.73M |